T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equifax
EFX
|
+$715M |
| 2 |
Linde
LIN
|
+$549M |
| 3 |
Xcel Energy
XEL
|
+$547M |
| 4 |
Intercontinental Exchange
ICE
|
+$533M |
| 5 |
AbbVie
ABBV
|
+$503M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$948M |
| 2 |
TE Connectivity
TEL
|
+$756M |
| 3 |
Yum! Brands
YUM
|
+$685M |
| 4 |
Becton Dickinson
BDX
|
+$666M |
| 5 |
Ingersoll Rand
IR
|
+$648M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Healthcare | 22.34% |
| 3 | Financials | 13.96% |
| 4 | Industrials | 11.89% |
| 5 | Consumer Discretionary | 11.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
John Marshall Bancorp
JMSB
$328M
| $41.7M | 0.03% |
1,449,621
-1,203
| -0.1% | -$33.5K |
|
377
RH
RH
$3.42B
| $41.7M | 0.03% |
155,925
+64
| +0% | +$16.7K |
|
378
Enpro
NPO
$7.21B
| $40.8M | 0.03% |
+375,012
| New | +$40.6M |
|
379
Kimbell Royalty Partners
KRP
$1.52B
| $40.7M | 0.03% |
2,435,664
+709,547
| +41% | +$12.5M |
|
380
Petco
WOOF
$822M
| $40.5M | 0.03% |
4,274,846
+1,636,087
| +62% | +$16.8M |
|
381
Arthur J. Gallagher & Co
AJG
$64.4B
| $40.5M | 0.03% |
214,869
+27,193
| +14% | +$5.09M |
|
382
Cavco Industries
CVCO
$4.62B
| $40M | 0.03% |
176,976
-550,361
| -76% | -$122M |
|
383
Arvinas
ARVN
$584M
| $39.4M | 0.03% |
1,152,793
-783
| -0.1% | -$32.9K |
|
384
Five Star Bancorp
FSBC
$1.16B
| $38.5M | 0.03% |
1,413,122
-426
| -0% | -$11.9K |
|
385
Metropolitan Bank Holding Corp
MCB
$1.17B
| $38.4M | 0.03% |
655,244
+255,585
| +64% | +$16.2M |
|
|
CHCT
386
Community Healthcare Trust
CHCT
$437M
| $38M | 0.03% |
1,061,674
+8,827
| +0.8% | +$301K |
|
387
InnovAge Holding
INNV
$1.45B
| $37.7M | 0.03% |
5,247,106
+224,136
| +4% | +$1.44M |
|
388
Vulcan Materials
VMC
$36.2B
| $37.2M | 0.03% |
212,500
-33,981
| -14% | -$5.81M |
|
389
MaxLinear
MXL
$7.02B
| $36.9M | 0.03% |
1,086,933
-321,697
| -23% | -$10.9M |
|
390
WillScot Mobile Mini Holdings
WSC
$4.08B
| $36.7M | 0.03% |
811,652
-82,750
| -9% | -$3.71M |
|
|
CWAN
391
DELISTED
Clearwater Analytics
CWAN
| $36.7M | 0.03% |
1,954,998
+8,284
| +0.4% | +$143K |
|
392
Coastal Financial
CCB
$779M
| $36.6M | 0.03% |
769,791
+160,706
| +26% | +$7.45M |
|
393
H.B. Fuller
FUL
$3.22B
| $36.6M | 0.03% |
+510,729
| New | +$36.9M |
|
394
Southern First Bancshares
SFST
$610M
| $36.6M | 0.03% |
799,080
+117,405
| +17% | +$5.33M |
|
395
PROG Holdings
PRG
$1.7B
| $36M | 0.03% |
2,129,384
+576,086
| +37% | +$9.84M |
|
396
Hawkins
HWKN
$2.71B
| $35.6M | 0.03% |
922,377
-24,946
| -3% | -$1.03M |
|
|
BLFY
397
DELISTED
Blue Foundry Bancorp
BLFY
| $35.5M | 0.03% |
2,761,391
-1,189
| -0% | -$14.7K |
|
|
ICVX
398
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $35.4M | 0.03% |
4,463,525
+1,148,465
| +35% | +$4.93M |
|
|
VERV
399
DELISTED
Verve Therapeutics
VERV
| $34.8M | 0.03% |
1,799,650
+544,834
| +43% | +$14.4M |
|
400
FIGS
FIGS
$2.44B
| $34.6M | 0.03% |
5,141,192
+1,097,083
| +27% | +$7.89M |
|
Similar funds
T. Rowe Price Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Investment Management held 577 positions worth $130B, up 4.1% from $125B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Investment Management's Q4 2022 filing shows 38 new, 261 increased, 232 reduced and 36 closed positions. Its largest new stake was Xcel Energy: 8,228,100 shares worth $577M. The largest sale was Alphabet (Google) Class C, an estimated $948M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Investment Management's largest Q4 2022 buy was Xcel Energy: 8,228,100 shares worth $577M.
- T. Rowe Price Investment Management added most to Equifax in Q4 2022, an estimated $715M increase.
- T. Rowe Price Investment Management's biggest Q4 2022 reduction was TE Connectivity, cutting an estimated $756M.
- T. Rowe Price Investment Management fully exited Alphabet (Google) Class C in Q4 2022, selling an estimated $948M.
- T. Rowe Price Investment Management's ten largest holdings make up 16% of its $130B portfolio in Q4 2022.
- T. Rowe Price Investment Management opened 38 new positions and closed 36 in Q4 2022.
- T. Rowe Price Investment Management's portfolio value rose 4.1% quarter-over-quarter to $130B.
Based on T. Rowe Price Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.